Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project.
Saved in:
| Title: | Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project. |
|---|---|
| Authors: | Shaw B; Department of Haematology Monash Health Clayton Australia.; School of Public Health and Preventive Medicine, Monash University Melbourne Australia., Chung E; School of Public Health and Preventive Medicine, Monash University Melbourne Australia., Wellard C; School of Public Health and Preventive Medicine, Monash University Melbourne Australia., Yoo E; Department of Haematology Sir Charles Gairdner Hospital Perth Australia., Bennett R; Department of Haematology Peter MacCallum Cancer Centre Melbourne Australia., Birks C; Concord Hospital Sydney Australia., Johnston A; Department of Clinical Haematology Royal Hobart Hospital Hobart Australia., Cheah CY; Department of Haematology Sir Charles Gairdner Hospital Perth Australia.; Medical School, University of Western Australia Nedlands Australia., Hamad N; Department of Haematology St Vincent's Hospital Sydney Australia.; School of Clinical Medicine, Faculty of Medicine and Health UNSW Sydney Australia.; School of Medicine University of Notre Dame Australia Sydney Australia., Simpson J; Department of Haematology Port Macquarie Base Hospital Port Macquarie Australia., Barraclough A; Department of Haematology Fiona Stanley Hospital Perth Australia., Ku M; Department of Haematology St Vincent's Hospital Melbourne Australia.; Faculty of Medicine University of Melbourne Melbourne Australia., Viiala N; Department of Haematology Liverpool Hospital Sydney Australia.; South West Sydney Clinical Campus, School of Clinical Medicine, Faculty of Medicine and Health UNSW Sydney Australia., Ratnasingam S; Department of Clinical Haematology University Hospital Geelong Geelong Australia., Armytage T; Department of Haematology Gosford Hospital Gosford Australia., Cochrane T; Department of Haematology Gold Coast University Hospital Gold Coast Australia.; Griffith University Gold Coast Australia., Chong G; Department of Medical Oncology Grampians Health Ballarat Australia., Lee D; Department of Haematology Eastern Health Melbourne Australia., Manos K; Department of Haematology Flinders Medical Centre Adelaide Australia., Keane C; Department of Haematology Princess Alexandra Hospital Brisbane Australia., Wallwork S; Department of Haematology Princess Alexandra Hospital Brisbane Australia., Opat S; Department of Haematology Monash Health Clayton Australia.; School of Public Health and Preventive Medicine, Monash University Melbourne Australia., Hawkes EA; School of Public Health and Preventive Medicine, Monash University Melbourne Australia.; Department of Medical Oncology and Clinical Haematology Olivia Newton-John Cancer Research Institute at Austin Health Heidelberg Australia. |
| Source: | EJHaem [EJHaem] 2024 Feb 23; Vol. 5 (2), pp. 325-332. Date of Electronic Publication: 2024 Feb 23 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
